Posted in | News | Mining Business

Brazil Minerals' Duas Barras Added to the List of Top 200 Mines in Brazil

Brazil Minerals, Inc. (the "Company" or "BMIX") announced today that its subsidiary and diamond and gold miner, Mineração Duas Barras Ltda ("Duas Barras"), is being added to the list of the Top 200 Mines in Brazil.

This ranking, compiled by Revista Minérios & Minerales, a leading industry publication, is made on the basis of volume of the primary mineral extracted in a given mine. Duas Barras expects to achieve the number one or two ranking for diamond mine in Brazil when the list is published.

"Diamonds Regain Their Sparkle for Miners on Rising Demand and Prices - Sector Now Delivering Some of the Healthiest Returns in the Mining World"

Recently, The Wall Street Journal published a news report entitled "Diamonds Regain Their Sparkle for Miners on Rising Demand and Prices - Sector Now Delivering Some of the Healthiest Returns in the Mining World". The Company believes that this article provides important background to understand the current favorable dynamics in the diamond business. The link to the online version of this report is here:

Invited Presentation

BMIX received a formal invitation to present its diamond-producing subsidiary, Duas Barras, at the 12th annual edition of the Equipo Mining Conference being held in Belo Horizonte, Brazil, August 5-8, 2014. Marc Fogassa, Chairman and CEO, and Robledo Delatorre Ribeiro, Head of Operations in Brazil, will present and be available for meetings at the conference.

About Brazil Minerals, Inc.

Brazil Minerals, Inc. (OTCQB: BMIX), a U.S. holding corporation, has ownership of 73.75% of Duas Barras, a Brazilian mining company that mines diamonds and gold, and sells polished and rough diamonds as well as gold bars with 96% purity. BMIX also owns stakes in other subsidiaries in Brazil with mineral rights and/or options on projects in diamonds, gold, and other minerals. More information on BMIX, including an investor presentation, can be found at

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.